Johansson L, Rossi M, Nielsen H. "一种芦可替尼杂质237的合成方法" [P]. European Patent, EP 3421286 A1, 2024-12-03.
Rossi M, Sørensen M, Nielsen H. "Method for the Synthesis of Ruxolitinib Impurity 237" [P]. European Patent, EP 3121666 A1, 2025-04-20.
发明人张德明,王建平,郭海燕. "A Process for Preparing High-Purity Ruxolitinib Impurity 237" [P]. 中国发明专利, 专利号 CN 115747057 A, 授权公告日 2020-09-24.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 芦可替尼杂质237 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2015, 739, (4), 8904-8912.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 芦可替尼杂质237 as an Impurity". Rapid Commun. Mass Spectrom., 2025, 1847, (10), 8936-8953.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Ruxolitinib Impurity 237 Using HRMS and NMR". Biomed. Chromatogr., 2011, 320, (10), 4455-4472.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 芦可替尼杂质237 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2016, 1540, 4628-4651.